3-Me-PVP
Synthetic stimulant drug
3-Me-PVP | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
3-Methyl-α-pyrrolidinopentiophenone (3-Me-PVP) is a synthetic drug of the cathinone class. It is a stimulant that has been sold online as a designer drug.
Chemical structure and properties
3-Me-PVP is a derivative of α-pyrrolidinopentiophenone (α-PVP), where a methyl group is added to the third position of the phenyl ring. This modification results in a compound with the chemical formula C16H23NO. The presence of the pyrrolidine ring is a common feature in this class of compounds, contributing to their stimulant effects.
Pharmacology
3-Me-PVP acts as a norepinephrine-dopamine reuptake inhibitor (NDRI), which means it increases the levels of the neurotransmitters norepinephrine and dopamine in the brain by inhibiting their reuptake into neurons. This action is responsible for its stimulant effects, which can include increased alertness, euphoria, and enhanced physical performance.
Effects and usage
The effects of 3-Me-PVP are similar to those of other synthetic cathinones, such as mephedrone and MDPV. Users report feelings of euphoria, increased energy, and heightened alertness. However, the use of 3-Me-PVP can also lead to adverse effects such as anxiety, paranoia, and cardiovascular issues.
Legal status
The legal status of 3-Me-PVP varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of medical use. It is often included in legislation targeting synthetic cathinones and other designer drugs.
Health risks
The use of 3-Me-PVP carries significant health risks. Acute effects can include tachycardia, hypertension, and hyperthermia. Chronic use may lead to psychological dependence and other long-term health issues. As with other synthetic stimulants, the risk of overdose is a serious concern.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD